• Breaking the Therapeutic Ceiling in Crohn's Disease

  • Aug 23 2022
  • Length: 25 mins
  • Podcast

Breaking the Therapeutic Ceiling in Crohn's Disease

  • Summary

  • Drs Peter Higgins and Bram Verstockt discuss breaking the therapeutic ceiling in Crohn's disease and the differential effectiveness of therapies and phenotypes in identifying responses to treatment.

    Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/967626). The topics and discussions are planned, produced, and reviewed independently of advertiser. This podcast is intended only for US healthcare professionals.

    Resources

    Crohn's Disease https://emedicine.medscape.com/article/172940-overview

    A Blood-Based Prognostic Biomarker in IBD https://gut.bmj.com/content/68/8/1386

    Role of the IL23/IL17 Pathway in Crohn's Disease https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8042267/

    A Study of Efficacy and Safety of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Ulcerative Colitis (VEGA) https://clinicaltrials.gov/ct2/show/NCT03662542

    Results of Novel Clinical Study Show Adults With Moderately to Severely Active Ulcerative Colitis Achieved Higher Rates of Clinical Response, Clinical Remission, and Endoscopic Improvement at 12 Weeks With Guselkumab and Golimumab Combination Therapy Versus Either Monotherapy Alone https://www.prnewswire.com/news-releases/results-of-novel-clinical-study-show-adults-with-moderately-to-severely-active-ulcerative-colitis-achieved-higher-rates-of-clinical-response-clinical-remission-and-endoscopic-improvement-at-12-weeks-with-guselkumab-and-golimumab-301486054.html

    Digestive Disease Week 2022 https://ddw.org/

    Triple Combination Therapy in High Risk Crohn's Disease (CD) https://clinicaltrials.gov/ct2/show/NCT02764762

    Anti-TNF and Crohn's Disease: When Should We Stop? http://www.eurekaselect.com/article/15866

    Show more Show less
activate_Holiday_promo_in_buybox_DT_T2

What listeners say about Breaking the Therapeutic Ceiling in Crohn's Disease

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.